Undervalued Small-Cap Growth Stocks on NYS January 2026

January 08, 2026

Growth Stocks

A company is considered a growth stock when it has grown its revenue significantly in the latest quarterly report.

New York Stock Exchange

The New York Stock Exchange, located in New York City, is the largest securities exchange in the world by market capitalization of its listed companies.

Small, Micro and Nano-Cap

Stocks in the Small, Micro and Nano Market Cap groups have a market capitalization of less than $2 billion.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued Growth Stocks

Stocks in this category are held primarily for capital appreciation and while they present upside opportunity, they also present downside risk.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
YCBD cbdMD Inc 0.77 4.08 427.13 211230 0 0.00 1.4
RBOT Vicarious Surgical Inc. 2.66 13.78 418.05 83364 16 0.00 0.0
TOVX Theriva Biologics Inc. 0.27 1.34 396.30 2327932 1 0.00 0.1
UAVS Ageagle Aerial Systems In 1.32 6.12 363.64 1459562 1 0.00 0.0
NPWR NET Power Inc. 2.90 12.99 347.93 1473257 223 0.00 0.0
DAVA Endava Ltd 6.46 28.46 340.56 1361450 384 0.00 29.4
ASPN Aspen Aerogels Inc 3.36 14.48 330.95 3498656 276 0.00 0.0
SOC Sable Offshore Corp. 4.19 16.55 294.99 8538693 354 0.00 0.0
ANVS Annovis Bio Inc 2.43 9.28 281.89 470112 42 0.00 0.0
CVM CEL-SCI Corp 7.05 26.69 278.64 109668 20 0.00 0.0
All data provided as at market close November 12, 2025.

Company Details

cbdMD Inc

YCBD:NYS

Close Price

0.77

Our Valuation

4.08

% Difference

427.13

Market Cap ($M)

0

P/E Ratio

1.4

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, ready to drink cans, and sleep, focus, and calming aids.

Access the stockcalc valuation


Vicarious Surgical Inc.

RBOT:NYS

Close Price

2.66

Our Valuation

13.78

% Difference

418.05

Market Cap ($M)

16

P/E Ratio

0.0

Vicarious Surgical Inc. develops and sells single-port surgical robot in the United States. It offers Vicarious Surgical System, a single-port surgical robot that virtually transports surgeons inside the patient to perform invasive surgery. The company was founded in 2014 and is headquartered in Waltham, Massachusetts.

Access the stockcalc valuation


Theriva Biologics Inc.

TOVX:NYS

Close Price

0.27

Our Valuation

1.34

% Difference

396.30

Market Cap ($M)

1

P/E Ratio

0.1

Theriva Biologics, Inc., a clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the United States.

Access the stockcalc valuation


Ageagle Aerial Systems In

UAVS:NYS

Close Price

1.32

Our Valuation

6.12

% Difference

363.64

Market Cap ($M)

1

P/E Ratio

0.0

AgEagle Aerial Systems, Inc., doing business as EagleNXT, through its subsidiaries, designs and delivers autonomous uncrewed aerial systems worldwide. It operates through three segments: Drones, Sensors, and Software-as-a-Service (SaaS).

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

NET Power Inc.

NPWR:NYS

Close Price

2.90

Our Valuation

12.99

% Difference

347.93

Market Cap ($M)

223

P/E Ratio

0.0

NET Power Inc. operates as an energy technology company in the United States. Its technology includes NET Power Cycle, a power generation system that produces electricity from natural gas while capturing atmospheric emissions. The company was founded in 2010 and is headquartered in Durham, North Carolina.

Access the stockcalc valuation


Endava Ltd

DAVA:NYS

Close Price

6.46

Our Valuation

28.46

% Difference

340.56

Market Cap ($M)

384

P/E Ratio

29.4

Endava plc, together with its subsidiaries, provides technology services in North America, Europe, the United Kingdom, and internationally.

Access the stockcalc valuation


Aspen Aerogels Inc

ASPN:NYS

Close Price

3.36

Our Valuation

14.48

% Difference

330.95

Market Cap ($M)

276

P/E Ratio

0.0

Aspen Aerogels, Inc., an aerogel technology company, designs, develops, manufactures, and sells aerogel materials primarily for use in the energy industrial, sustainable insulation materials, and electric vehicle (EV) markets in the United States, Canada, Asia, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Access the stockcalc valuation


Sable Offshore Corp.

SOC:NYS

Close Price

4.19

Our Valuation

16.55

% Difference

294.99

Market Cap ($M)

354

P/E Ratio

0.0

Sable Offshore Corp. operates as an independent oil and gas company in the United States. The company operates through three platforms located in federal waters offshore California. It also owns and operates 16 federal leases across approximately 76,000 acres, as well as subsea pipelines that transports crude oil, natural gas, and produced water from the platforms to the onshore processing facilities. The company was formerly known as Flame Acquisition Corp.

Access the stockcalc valuation


Annovis Bio Inc

ANVS:NYS

Close Price

2.43

Our Valuation

9.28

% Difference

281.89

Market Cap ($M)

42

P/E Ratio

0.0

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's lead product candidate is Buntanetap, which is in phase 2/3 to treat alzheimer's disease, as well as in phase 3 to treat parkinson's disease; and is in phase 2 clinical trial to treat lewy body dementia.

Access the stockcalc valuation


CEL-SCI Corp

CVM:NYS

Close Price

7.05

Our Valuation

26.69

% Difference

278.64

Market Cap ($M)

20

P/E Ratio

0.0

CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States. The company's lead immunotherapy is Multikine, which has completed Phase III clinical trials for the potential treatment of certain head and neck cancers.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
cbdMD and Vicarious Surgical are the most undervalued Small-Cap growth stocks on the NYS. See the full list of undervalued growth stocks here: https://www.stockcalc.com/Blog/undervalued-small-cap-growth-stocks-nys-january-2026
cbdMD $YCBD and Vicarious Surgical $RBOT are the most undervalued Small-Cap growth stocks on the #NYS. See the full list: https://www.stockcalc.com/Blog/undervalued-small-cap-growth-stocks-nys-january-2026
cbdMD and Vicarious Surgical are the most undervalued Small-Cap growth stocks on the NYS. See the full list of undervalued growth stocks here: https://www.stockcalc.com/Blog/undervalued-small-cap-growth-stocks-nys-january-2026

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.